• LAST PRICE
    1.4100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 1.4100
  • Day Range
    ---
  • 52 Week Range
    Low 1.4000
    High 35.3600
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 1.44
TimeVolumeSEQL
11:56 ET7501.41
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSEQL
SeqLL Inc
536.7K
-0.1x
---
United StatesQTXB
Quantrx Biomedical Corp
314.8K
-1.2x
---
United StatesPCNT
Point of Care Nano-Technology Inc
4.2K
-0.1x
---
United StatesNNMX
Nanomix Corp
4.9K
0.0x
---
United StatesBLFE
Biolife Sciences Inc
3.2K
0.0x
---
United StatesNVIVQ
InVivo Therapeutics Holdings Corp
1.1M
-0.1x
---
As of 2024-04-24

Company Information

SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and intellectual property across multiple omics fields. The Company is engaged in the design, development and manufacturing of genetic analysis technologies. It leverages its True Single Molecule Sequencing (tSMS) technology, which enables researchers and clinicians to contribute advancements to scientific research and development. Its tSMS platform offers a single molecule solution for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing by performing detection of nucleic acids without the need for complex sample manipulation. Researchers using its platform can analyze billions of single molecules in a single experiment and generate reproducible data. Its single molecule platform combines a fluorescence-based optical detection apparatus with a precision microfluidics and thermal control system to perform sequencing-by-synthesis.

Contact Information

Headquarters
317 New Boston St Ste 210WOBURN, MA, United States 01801-6231
Phone
781-817-3755
Fax
302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer
Daniel Jones
Chief Financial Officer, Secretary
Frances Scally
Independent Director
Patrice Milos
Independent Director
Douglas Miscoll
Independent Director
David Pfeffer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$536.7K
Revenue (TTM)
$0.00
Shares Outstanding
380.7K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-15.96
Book Value
$1.60
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.